Čeština 
Slovenčina 
Română 
Deutsch LIBROXAR
Substitution treatment for opioid drug dependence within a framework of medical, social and psychological treatment
QUALITATIVE AND QUANTITATIVE COMPOSITION
buprenorphinum/naloxonum 8 mg/2 mg
THERAPEUTIC INDICATIONS
Opioid substitution treatment in medical, social and psychological care. The purpose of the naloxone component is to prevent improper intravenous use.
The treatment is intended for use in adults and adolescents over 15 years of age who have agreed to treat addiction.
DISPENSING AND REIMBURSEMENT
Medicinal product is subjected to medical prescription. The medicinal product is covered by public health insurance.
Mandatory information
